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Background: Inorganic pyrophosphate-type 
phosphoenolpyruvate carboxylase (PPi-PEPCK) 
was unidentified. 
Results: A conserved hypothetical protein was 
annotated as PPi-PEPCK. 
Conclusion: PPi-PEPCK arose independently 
from the functional homologs, ATP/GTP-PEPCKs 
or PEP carboxylase. 
Significance: Identification of PPi-PEPCK 
reveals the wide distribution of this enzyme and 
accelerates understanding the diversity of the 
central metabolism. 
 
ABSTRACT  
Phosphoenolpyruvate carboxykinase (PEPCK) is 
one of the pivotal enzymes, which regulates the 
carbon flow of the central metabolism by fixing 
CO2 to phosphoenolpyruvate (PEP) to produce 
oxaloacetate or vice versa. While ATP- and 
GTP-type PEPCKs have been well studied and 
their protein identities are established, inorganic 
pyrophosphate (PPi)-type PEPCK (PPi-PEPCK) is 
poorly characterized. Despite extensive 
enzymological studies, its protein identity and 
encoding gene remain unknown. In this study, 
PPi-PEPCK has been identified for the first time 
from an eukaryotic human parasite, Entamoeba 
histolytica, by conventional purification and mass 
spectrometric identification of the native enzyme, 
followed by demonstration of its enzymatic 
activity. A homolog of the amebic PPi-PEPCK 
from an anaerobic bacterium Propionibacterium 
freudenreichii subsp. shermanii also exhibited 
PPi-PEPCK activity. The primary structure of 
PPi-PEPCK has no similarity to the functional 
homologs ATP/GTP-PEPCKs or PEP carboxylase, 
strongly suggesting that PPi-PEPCK arose 
independently from the other functional 
homologues and highly likely has unique catalytic 
sites. PPi-PEPCK homologs were found in a 
variety of bacteria and some eukaryotes, but not in 
archaea. The molecular identification of this 
long-forgotten enzyme tells us the diversity and 
functional redundancy of enzymes involved in the 
central metabolism and would help us to 
understand the central metabolism more deeply. 
 
Inorganic pyrophosphate (PPi) is composed 
of two molecules of phosphate (Pi) linked by a 
phosphoanhydride bond. PPi has been proposed as 
an evolutionary precursor of ATP and GTP (1) 
since this structurally simple compound can be 
formed spontaneously and the hydrolysis of PPi 
produces high energy (2,3). If ancestral organisms 
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could utilize only PPi or polyphosphates as an 
energy and/or phosphate donor for enzymatic 
reactions, there should have been an event in 
which new enzymes utilizing ATP/GTP arose. 
This further raises the question of how organisms 
change the major substrate; by accumulation of 
mutation on the enzyme to change the substrate 
specificity from PPi to nucleotide triphosphate or 
the substitution of PPi-utilizing enzymes by an 
independently emerged functional homolog that 
utilize nucleotide triphosphates. To gain insight 
into the evolutionary transition from PPi to 
nucleotide triphosphate, evolutionary relationship 
between the extant PPi- and ATP/GTP- utilizing 
enzymes has been examined (4-11).  
In glycolytic/gluconeogenic pathways and 
the closely related reactions in current organisms, 
three enzymatic reactions that can utilize PPi as 
the substrate have been reported. The first one is 
PPi-dependent phosphofructokinase (PFK) (EC 
2.7.1.90) reaction. PPi-PFK catalyzes reversible 
reaction while ATP-dependent PFK (EC 2.7.1.11) 
catalyze irreversible reaction. 
 
PPi + D-fructose 6-phosphate <=> Pi + 
D-fructose 1,6-bisphosphate 
ATP + D-fructose 6-phosphate => ADP + 
D-fructose 1,6-bisphosphate 
 
PPi-PFKs from an eukaryotic human parasite 
Entamoeba histolytica (12) and an anaerobic 
bacterium Propionibacterium freudenreichii subsp. 
shermanii (13) were proposed to work for fructose 
1,6-bisphosphatase synthesis like ATP-PFKs. In 
higher plants, it has been shown that PPi-PFK 
works in the opposite direction at least during 
internode developmental stages (14). Therefore, 
PPi-PFK can catalyze both PPi-utilizing and 
PPi-producing reactions not only in vivo but also 
in vitro. ATP- and PPi-PFK share a common 
origin, but the evolutionary history is highly 
complex. Change of the phosphate donors in 
PFKs occurred more than once, as suggested by 
phylogenetic analyses of ATP- and PPi-PFKs 
(6,9,10,15). The complex evolution of substrate 
utility in PFK suggests, at least in PFK, the 
transition of PPi-utilizing and nucleotide 
triphosphate-utilizing ability can have occurred 
relatively easily. Indeed, just a few-amino acid 
mutation can change the substrate preference from 
PPi to ATP based on the ratio of kcat/Km (8).  
The second reaction utilizing PPi is 
catalyzed by pyruvate phosphate dikinase (PPDK; 
EC 2.7.9.1): 
 
  PPi + AMP + PEP <=> Pi + ATP + pyruvate 
 
PEP–pyruvate conversion is also catalyzed by 
PPi-independent enzymes, PEP synthase (EC 
2.7.9.2: upper formula of the below) and pyruvate 
kinase (EC 2.7.1.40: lower formula of the below): 
 
Pi + AMP + PEP <=> ATP + pyruvate 
  ADP + PEP => ATP + pyruvate 
 
PPDK and PEP synthase share conserved domains 
while overall amino acid sequence similarity is 
not high (16). On the other hand, neither PPDK 
nor PEP synthase shows substantial similarity to 
pyruvate kinase at the primary structure level. 
This case is apparently distinguishable from that 
of PFK because transition of substrate utility for 
the PEP-pyruvate conversion has not been 
happened by simple amino acid substitutions as 
seen in PFK.  
The third mechanism is PEP-oxaloacetate 
interconverting reaction catalyzed by 
phosphoenolpyruvate carboxykinase (PEPCK). 
Because PEP is a key intermediate in a variety of 
metabolic processes in all living organisms 
(17,18), PEPCK works as a major crossroad that 
connects glycolysis/gluconeogenesis and organic 
acids metabolisms like TCA cycle and fumarate 
fermentation. According to the phosphate donor to 
oxaloacetate, PEPCK can be divided into three 
types: GTP- (EC 4.1.1.32), ATP- (EC 4.1.1.49), 
and PPi- (EC 4.1.1.38). PEPCK reactions are 
fundamentally reversible; however, ATP- and 
GTP-PEPCKs prefer a PEP-producing reaction 
whereas PPi-PEPCK prefers an 
oxaloacetate-producing reaction at least in vitro 
(19). PEP carboxylase (EC 4.1.1.31) also 
catalyzes PEP-oxaloacetate interconversion, but 
this reaction is irreversible and requires HCO3
- 
instead of CO2 (18,20). 
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  GTP + oxaloacetate <=> GDP + PEP + CO2 
   ATP + oxaloacetate <=> ADP + PEP + CO2 
   PPi + oxaloacetate <=> Pi + PEP + CO2 
Pi + oxaloacetate <= PEP + HCO3
- 
 
ATP- and GTP-PEPCKs and PEP 
carboxylase have been well characterized. 
ATP-PEPCKs are mainly present in bacteria, yeast 
and plants, while GTP-PEPCKs are mostly 
present in higher eukaryotes, archaea and some 
bacteria (21). PEP carboxylase exists in various 
bacteria, and limited archaea and eukaryotes. 
Although there is no discernible similarity in the 
overall structure of these proteins, the residues 
implicated for the binding to metal, 
oxaloacetate/PEP, and nucleotides are conserved 
between ATP- and GTP-PEPCKs (22,23), while 
conservation of these residues has not been 
reported in the case of PEP carboxylases. In 
contrast, the information on PPi-PEPCK, which is 
also called as PEP carboxytransphosphorylase, is 
limited. Although PPi-PEPCK was previously 
purified from P. freudenreichii subsp. shermanii 
(19,24-26) and E. histolytica (27) and extensively 
characterized enzymologically, the gene encoding 
PPi-PEPCK remaines unknown since the first 
description in 1961 (24). Both the distribution of 
PPi-PEPCK among three domains of life and the 
evolutionary relationship between other PEP–
oxaloacetate interconverting enzymes were totally 
obscure.  
In the present study, we identified the 
protein for PPi-PEPCK activity and its encoding 
gene from E. histolytica and P. freudenreichii. The 
identification of PPi-PEPCK finally enabled us to 
compare the amino-acid sequences of all the three 
types of PEPCKs as well as PEP carboxylase. It 
also allowed us to estimate the distribution of 
PPi-PEPCK in the tree of life. Lastly, we argued 
the complex evolutionary history of proteins 
utilizing different substrates for the same catalytic 
reaction. 
 
EXPERIMENTAL PROCEDURES 
Microorganisms and cultivation– 
Trophozoites of E. histolytica clonal strain HM-1: 
IMSS Cl6 was maintained axenically in 
Diamond’s BI-S-33 medium (28) at 35.5°C as 
described previously. Cells were grown to the 
late-logarithmic phase (2-3 days after inoculation), 
harvested by the addition of ice-cold PBS buffer 
to culture flasks, after discarding the medium, and 
followed by centrifugation at 300 × g for 5 min at 
4°C. For protein purification, the harvested cell 
pellets were stored at -80 °C until use.  
Enzyme assays– PPi and 
oxaloacetate-producing direct PEPCK activity 
was assayed by measuring the oxidation of NADH 
by detecting the decrease of absorbance at 340 nm 
as described previously (27). Reaction mixture 
contained 10 mM potassium phosphate buffer (pH 
6.5), 0.4 mM PEP, 0.1 mM CoCl2, 20 mM KHCO3, 
10 mM MgCl2, 2.0 U mL
–1 malate dehydrogenase 
(from rabbit muscle; Sigma), 0.25 mM NADH, 
and an enzyme solution. Reaction was started by 
adding PEP, and the NADH oxidizing activity 
without the addition of PEP was subtracted as the 
base line. To get the absolute active value, 400 µL 
of the reaction mixture was added in 1.0 cm 
path-length cuvettes and absorbance was 
monitored by a spectrometer. To get the relative 
activity during the purification, 100 µL of the 
mixture was put in a 96 well plate, incubated at 
37˚C, and 340 nm was monitored by a micro-plate 
reader. One unit of activity was defined as the 
amount of enzyme oxidizing 1 µmol of NADH 
min–1.  
Purification of native E. histolytica PEPCK– 
EhPEPCK was purified from 5 g of wet cells as 
follows. The cells were suspended in 15 mL of 20 
mM Tris-HCl (pH 8.0) containing 0.1 mM CoCl2 
(buffer A) and 0.5 mg mL–1 E-64, disrupted by 
freezing and thawing, and cell debris was then 
removed by centrifugation at 100,000 × g for 1 h. 
After the supernatant was diluted to 30 mL with 
buffer A, ammonium sulfate was added to give 
30% saturation. The samples were then applied to 
a Butyl-Toyopearl column (22 mm × 15 cm; 
Tosoh, Tokyo, Japan) equilibrated with buffer A 
supplemented with ammonium sulfate at 30% 
saturation. All chromatography steps were 
performed using an ÄKTA purifier system (GE 
Healthcare, NJ, USA) at room temperature. 
Proteins were eluted with a gradient of ammonium 
sulfate from 30% to 0% at a flow rate of 4 mL 
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min–1. The active fractions were desalted using 
PD10 column (GE Healthcare) and then applied to 
a MonoQ HR 5/5 column (bed volume, 1 mL; GE 
Healthcare) equilibrated with buffer A. Proteins 
were eluted with a gradient of NaCl from 0 to 500 
mM for 20 column volume at a flow rate of 1.0 
mL min–1. The active fractions were pooled and 
loaded onto a Superdex 200 (10/300) column (GE 
Healthcare). Proteins were eluted with buffer A 
supplemented with 150 mM NaCl.  
Identification of EhPEPCK by LC-MS/MS 
analysis— ~130 kDa bands were excised from 
silver stained gel and subjected to the LC-MS/MS 
analysis, at W. M. Keck Biomedical Mass 
Spectrometry Laboratory, University of Virginia, 
USA. The analysis was performed almost the 
same as before (29); only the difference was that 5 
µL of the extract was injected to a reversed-phase 
capillary column and peptides were eluted over 
0.3 hours. 
To estimate the relative ratio of EhPEPCK1, 2 
and 3 in the analyzed sample, the peak area for the 
selected ion chromatogram of the monoisotopic 
mass of the most abundant charge state (+/- 
0.02Da) for each peptide was quantified. Three 
peptides conserved to all the three proteins, 
specific to EhPEPCK1, and conserved only in 
EhPEPCK2 and 3, respectively and one peptide 
unique to EhPEPCK2 or 3, respectively were 
selected for the analysis because these peptides 
were detected from all the three samples; 
immunoprecipitated samples (see below) using 
EhPEPCK1-HA, EhPEPCK2-HA, and purified 
PPi-PEPCK from the wild-type ameba lysate. 
Sum of the peak area value of the three peptides 
conserved to all was used for normalization.   
Construction of plasmids– For expression in 
Escherichia coli, the protein coding sequence of 
EhPEPCK1 (XP_654765.1) and 2 (XP_650862.1) 
genes were PCR-amplified from E. histolytica 
cDNA using a pair of following forward and 
reverse primers: 
5’-TCGAAGGTAGGCATATGTTTAATCAAGA
AAAAGGTACC-3’ (PEPCK_1_pCold_F) and 
5’-ATTCGGATCCCTCGATTAATGTTTCATGC
ATTTGTATG-3’ (PEPCK_1_2_pCold_R) for 
PEPCK1; 
5’-TCGAAGGTAGGCATATGTTTAATCAAGA
ACAAGGTA-3’ (PEPCK_2_pCold_F), and 
PEPCK_1_2_pCold_R for PEPCK2. For 
expression in E. histolytica trophozoites with 
hemagglutinin (HA) tag at the C-termini, the 
protein coding sequence of EhPEPCK1 and 2  
genes were PCR-amplified using the following 
primers: 
5’-ACACATTAACAGATCATGTTTAATCAAG
AAAAAGGTAC-3’ (PEPCK_1_pEhExHA_F) 
and 
5’-ATGGATACATAGAATGTTTCATGCATTTG
TATG-3’ (PEPCK_1_2_pEhExHA_R); and 5’- 
ACACATTAACAGATCATGTTTAATCAAGAA
CAAGGTA -3’ (PEPCK_2_pEhExHA_F), and 
PEPCK_1_2_pEhExHA_R, respectively. pColdI 
(Takara, Japan) and pEhExHA (30) plasmids were 
used for the expression in E. coli and E. 
histolytica, respectively. The amplified fragments 
were inserted into the plasmids cut with NdeI and 
XhoI (pColdI) or BglII (pEhExHA) using 
In-Fusion HD Cloning system (Takara, Japan).  
PPi-PEPCK gene from P. freudenreichii subsp. 
freudenreichii (PfPEPCK; LC062511) was 
PCR-amplified from the genomic DNA purchased 
from German Collection of Microorganisms and 
Cell Cultures (DSM 20271; DSMZ, Germany) 
using the following primers: 
5’-TCGAAGGTAGGCATAATGTCCGTAGTCG
AACGC-3’ (Pf_PEPCK_pCold_F) and 
5’-ATTCGGATCCCTCGATCAGACGAACCTG
GGCTG -3’ (Pf_PEPCK_pCold_R); and cloned 
into pColdI as described above.  
Overexpression and purification of recombinant 
PPi-PEPCKs–The plasmids for bacterial 
expression were introduced into E. coli BL21 
CodonPlus (DE3)-RIL (EhPEPCK1 and 2; 
Agilent) of and E. coli BL21 Star (DE3) 
(PfPEPCK; Life technologies). The hosts 
transformed with the expression plasmids were 
inoculated into 400 mL or Luria-Bertani medium 
in 1 L conical flask containing 50 µg mL–1 
ampicillin and 34 µg mL–1 chloramphenicol, if 
necessary. After cultivating the cells aerobically at 
37 °C until the OD600 reached approximately 0.5, 
protein expressions were induced by cooling the 
culture on ice for 30 min and adding 0.1 mM 
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isopropyl thio-β-d-galactopyranoside to the 
medium, followed by over-night cultivation at 
15 °C. Harvested cells (~8 g of wet cells from 1.2 
L of culture) were disrupted by adding BugBuster 
(~5 mL g–1 of wet cells; Merck) and cell debris 
was removed by centrifugation. Imidazole and 
NaCl concentrations in the supernatant were 
adjusted to 10 and 300 mM, respectively. The 
supernatant was then applied to an open column 
packed with Ni-NTA agarose (1.5 mL of bed 
volume; Qiagen). After washing the column with 
16 bed volume of 50 mM Tris-HCl, 300 mM NaCl, 
and 20 mM imidazole-HCl (pH 8.0), the 
His-tagged protein was eluted with 4 bed volume 
of the same buffer containing 250 mM 
imidazole-HCl. The eluted proteins were further 
purified using MonoQ column as described above.  
Antibodies– To make anti-EhPEPCK antisera, 
full-length EhPEPCK1 with His-tag at N terminus 
was expressed in E. coli, purified using Ni-NTA 
and MonoQ columns as described above, and used 
as the antigen. The anti-EhPEPCK1 antisera from 
rabbit were commercially raised by Operon 
Biotechnology (Tokyo, Japan). The specificity of 
these antibodies was confirmed using E. 
histolytica lysates by western blotting (WB) 
analysis (data not shown). 
Ameba transformation– The plasmids generated 
as described above were introduced into E. 
histolytica trophozoites by lipofection, as 
previously described (31) with minor 
modifications. Approximately 40 µl of the 
transfection medium containing 3-5 µg of one of 
the plasmids was mixed with 10 µl of PLUSTM 
reagent (Life Technologies) and kept at room 
temperature for 15 min. This mixture was 
combined with 20 µl of LipofectamineTM 
transfection reagent mixed with 30 µL of 
transfection medium, kept at room temperature for 
15 min, diluted with 400 µl of transfection 
medium, and added to the seeded trophozoites 
attached to 12 wells-plate after removing medium. 
The plate was then incubated at 35.5 °C for 5 h, 
and cells were transfer to a tube containing 5.5 mL 
of BIS medium. About 24 h after transfection, BIS 
medium was changed into fresh one with 1 µg/ 
mL of G418, and gradually increased for ∼ 2 
weeks until the G418 concentration reached 
10 µg/ mL.  
Protein assay– Protein concentrations were 
measured using a Bio-Rad protein assay DC dye. 
Bovine gamma globulin was used as a standard. 
WB– Protein samples were subjected to 
SDS-PAGE after boiled at 95˚C for 3 min with 
SDS-PAGE loading buffer. Proteins in the gel 
were transferred to nitrocellulose membrane and 
then blocked with 5% (w/v) skim milk in Tris 
buffered saline with Tween20 (TBST) for 
overnight at 4 ˚C. Proteins on the membrane were 
reacted with antibodies in TBST for 1 h at room 
temperature. Primary antibodies were used at a 
1:5000 dilution for anti-EhPEPCK rabbit antibody, 
a 1:1000 dilution for anti-cysteine synthase 1 (32) 
and anti-Cpn60 (33) rabbit antibodies, and 
anti-HA mouse monoclonal antibody (clone 
11MO, Covance, Princeton, NJ, USA). The blots 
were visualized using alkaline 
phosphatase-conjugated anti-rabbit or mouse IgG 
antibody (1:2000 dilution; Cell Signaling 
Technology, USA) with AP Color Reagent (Bio 
Rad, USA) according to the manufacturer's 
protocol. 
Immunoprecipitation– To examine the 
interaction between EhPEPCKs, 0.08 g of wet 
cells expressing PEPCK1-HA, PEPCK2-HA or 
only HA were lysed with 1 mL of lysis buffer (50 
mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1 mM 
CoCl2, 0.2% TritonX-100, 0.5 mg mL
–1 of E-64) 
for 10 min on ice. After centrifugation at 20,000 × 
g for 10 min, the supernatants were pre-cleaned 
with 150 µL of Protein G Sepharose (GE 
Healthcare, Waukesha, WI, USA) for 1h. After 
removing the beads by centrifugation, the 
precleared supernatant samples were mixed and 
incubated with 50 µL of anti-HA monoclonal 
antibody-conjugated agarose (Sigma-Aldrich, St. 
Louis, MO, USA) for 4 h. The agarose beads were 
washed with 400 µL of lysis buffer without E-64 
for 5 times (9,300 × g for 1 min each) to remove 
the unbound proteins, and the bound proteins were 
eluted by incubating with 200 µL of lysis buffer 
containing 0.2 mg mL–1 of HA peptide 
(Sigma-Aldrich) for over-night. The eluted 
samples were collected by centrifugation at 800 × 
g for 3 min. All the centrifugations and 
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incubations were done at 4˚C otherwise 
mentioned. 
Phylogenic analysis– Homologues of PPi-PEPCK 
were searched by the blastP analysis against 
non-redundant protein sequence database using 
EhPEPCK1 as a query (5th May 2015). In addition, 
we also retrieved the homologues of 
Mastigamoeba balamuthi and Spironucleus 
barkhanus by the tblastN analysis against the 
whole genome shotgun reads and the EST 
database, respectively. Other eukaryotic 
counterparts were retrieved by the tblastN analysis 
against the Marine Microbial Eukaryote 
Transcriptome Sequencing Project (MMETSP) 
database (34). No more than two sequences with 
97-100% amino acid sequence similarity were 
included, except for Entamoeba spp. and Giardia 
intestinalis (see discussion for the details). 
Sequences were aligned by MAFFT (35), and 
ambiguously aligned sites were excluded, 
resulting in the dataset comprising 158 taxa 749 
positions. The dataset was subjected to the ML 
method with the LG + Γ + F model. The ML tree 
was heuristically searched from ten distinct 
maximum parsimony (MP) trees. In ML bootstrap 
analyses (100 replicates), a heuristic tree search 
was performed from a single MP tree per replicate. 
The ML phylogenetic analyses described above 
were conducted by RAxML ver. 7.2.8 (36). 
 
RESULTS 
Identification of PPi-PEPCK from E. 
histolytica– In silico search of potential PEPCK 
homologs in the E. histolytica genome 
(AmoebaDB; http://amoebadb.org/amoeba/) using 
canonical ATP- and GTP-PEPCK from 
Dictyostelium discoideum (XP_645490.1 and 
XP_645396.1, respectively) failed to detect any 
candidate of PEPCK (data not shown) although 
PPi-PEPCK activity was detected from E. 
histolytica trophozoite lysates (0.165 U mg of 
protein–1) as previously reported by Reeves (27). 
PPi-PEPCK activity was sequentially separated 
using hydrophobic (Butyl-Toyopeal) and 
anion-exchange (MonoQ) columns (Table 1) and a 
MonoQ fraction containing peak PPi-PEPCK 
activity gave one major protein band at ~130 kDa 
on SDS-PAGE analysis (Fig. 1A). PPi-PEPCK 
activity detected in this MonoQ fraction indicated 
206-fold purification with a specific activity of 
34.0 U mg–1, which well agrees with the previous 
results of PPi-PEPCK from P. freudenreichii that 
showed 12.8 U mg–1 of activity after 99-fold 
purification (25). The activity level was also 
similar to ATP-PEPCK from Escherichia coli (24 
U mg–1) (37). Phosphate, PEP, and MDH 
dependence of the NADH oxidizing activity in the 
MonoQ fraction was also confirmed. NADH 
oxidizing activity was not detected when 
phosphate was substituted to ADP, indicating that 
the fraction did not contain ATP-PEPCK activity. 
The fraction containing PEPCK activity was 
further subjected to size-exclusion 
chromatography using Superdex 200. The 
PPi-PEPCK activity was detected in the fractions 
corresponding to two major peaks around ~143 
and ~440 kDa (Fig. 2). The integrated areas of the 
absorbance at 280 nm corresponding to the 
440-kDa and 143-kDa proteins (the first and 
second peaks, respectively) and their enzymatic 
activity levels are almost comparable, suggesting 
that active PPi-PEPCK is present as both 
monomer and trimer in E. histolytica (Fig. 2A). 
PPi-PEPCK from P. freudenreichii is previously 
reported to exist as monomer, dimer and tetramer 
with activity (26). Formation of several quaternary 
structures may be a character of PPi-PEPCK. 
Since both the fractions seemed to contain an 
identical ~130-kD protein band on SDS-PAGE, 
the protein band from the fractions corresponding 
to the first peak (~440 kDa) was excised and 
subjected to ToFMS/MS analysis. Peptides 
detected from the band correspond to a “cluster of 
hypothetical proteins”, which consist of three 
homologous proteins: EHI_166920 
(XP_654765.1), EHI_030750 (XP_650862.1), and 
EHI_198620 (XP_655201.1) (Table 2). The 
calculated molecular mass of these proteins (131 
kDa) well agreed with that expected from the 
SDS-PAGE result, and the detected peptides 
covered 63-67% of the three proteins. Hereinafter 
these proteins are designated as EhPEPCK1, 2, 
and 3, respectively. EhPEPCK1 and 2 or 3 showed 
91% amino acid identity, while EhPEPCK2 and 3 
showed 98% identity. Amino acid variations 
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between EhPEPCK1 and EhPEPCK2/3 were 
mainly found in the first 60 residues at the 
amino-terminal region, showing only 45% identity 
between EhPEPCK1 and EhPEPCK2/3. Neither 
of these proteins show any similarity to known 
proteins nor domains as predicted by Pfam 
(http://pfam.xfam.org/), indicating that the 
purified proteins were novel proteins.  
Confirmation of PPi-PEPCK activity of the 
amebic enzymes expressed in E. coli– EhPEPCK1, 
EhPEPCK2, and PfPEPCK were expressed as 
soluble recombinant proteins with the histidine tag 
at the amino terminus in E. coli. A Coomassie 
Brilliant Blue-stained SDS-PAGE gel of the 
proteins purified using Ni-NTA and MonoQ 
chromatography showed that the full length 
proteins of the expected size were purified to 
homogeneity (Fig. 1B). PPi-PEPCK activity of the 
purified EhPEPCK1, EhPEPCK2, and PfPEPCK 
were 8.9, 3.9, and 23.0 U mg–1, respectively, 
confirming that the identified genes indeed encode 
proteins with PPi-PEPCK activity. 
  Expression of EhPEPCK1 and 2 with HA-tag 
in E. histolytica– Amebic transformants 
expressing either EhPEPCK1 or EhPEPCK2 with 
the HA tag at the carboxyl terminus 
(EhPEPCK1-HA or EhPEPCK2-HA) using the 
episomal plasmid were established. Expression of 
the epitope-tagged proteins were confirmed by 
WB using anti-HA antibody (Fig. 3A). The 
molecular mass estimated from the band 
corresponding to EhPEPCK1-HA was slightly 
larger than that of EhPEPCK2-HA. We 
hypothesize that this subtle difference in the 
mobility between EhPEPCK1 and 2 is attributable 
to the difference in the isoelectric point between 
the two proteins. The isoelectric point values of 
EhPEPCK1 and 2 are calculated as 6.15 and 6.06, 
respectively. At this stage, we do not know if the 
slight difference in the isoelectric point and the 
molecular size between EhPEPCK1 and 2 is 
physiologically important.  
 
Heteromeric configuration of EhPEPCKs– To 
investigate whether EhPEPCKs form homo- or 
hetero-trimer, EhPEPCK1 and 2 were 
immuno-precipitated using lysates from 
transformants expressing corresponding 
EhPEPCK with the HA tag using anti-HA 
antibody. Both of the immuno-precipitated 
samples contained peptides from all the three 
EhPEPCKs (Table 3). When proteins were 
immuno-precipitated using EhPEPCK1-HA, 
EhPEPCK2/3 specific peptides were also detected 
while the relative ratio decreased about 1.7 folds 
compared to that of trimetric EhPEPCK purified 
from the wild-type E. histolytica. Similarly, the 
immuno-precipitated sample using 
EhPEPCK2-HA also contained peptides unique to 
EhPEPCK1 while the relative ratio decreased 2.0 
folds. These data suggest that some proportion of 
the trimer consists as the mixture of EhPEPCK1, 2, 
and 3. The detailed composition of the trimeric 
complex should be analyzed in future. 
Detection of PPi-PEPCKs by WB using 
anti-EhPEPCK antiserum– The anti-EhPEPCK 
antiserum reacted with recombinant PEPCK1 and 
2 with comparable efficiency (Fig. 3B). Major 
bands of the predicted molecular weight (~130 
kDa) were observed in E. histolytica’s lysate (Fig. 
3C), confirming the specificity of this 
anti-EhPEPCK antiserum. We estimated that 
EhPEPCKs account for approximately 1% of the 
total protein of the amebic lysate by comparing 
the band intensity of serially diluted recombinant 
PEPCKs and amebic lysates in WB analysis (Fig. 
3B). This estimation also agrees well with the 
result that about 200-folds purification of E. 
histolytica lysate gives highly purified 
PPi-PEPCK (Table 1 and Fig. 1A).  
Localization of PPi-PEPCKs in E. histolytica 
trophozoites– E. histolytica trophozoites were 
mechanically disrupted in sucrose-MOPS buffer 
and centrifuged to separate the cytosol and 
organelle/membrane fractions. The cytosolic 
marker, cysteine synthase 1 and the organelle 
marker, Cpn60 were demonstrated in the 
corresponding fractions (Fig. 4). When these 
fractions were reacted with anti-EhPEPCK 
antiserumn, clear bands were detected from the 
supernatant fraction. Therefore, major parts of 
both EhPEPCK1 and 2/3 localize in the cytosol 
(Fig. 4), while two isoforms of GTP-PEPCK exist 
in the cytosol and mitochondria in case of animals 
(38).  
In silico analysis to find organelle targeting 
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signals (TargetP 1.1, 
http://www.cbs.dtu.dk/services/TargetP/; SignalP 
4.1, http://www.cbs.dtu.dk/services/SignalP/), or 
transmembrane regions (TMHMM Server v. 2.0, 
http://www.cbs.dtu.dk/services/TMHMM/) did not 
detect any targeting signals and thus were 
consistent with the result from the wet experiment 
described above.  
Distribution of PPi-PEPCK in the tree of life– 
Homologs of EhPEPCKs were found in limited 
lineages of eukaryotes and bacteria, but not in 
archaea (Table 4 and 5). PPi-PEPCK genes were 
found in all the three genomes of Entamoeba 
species which were currently present in GenBank, 
although the copy numbers are different amongst 
the three. PPi-PEPCK gene was also found in the 
genome data of a free-living amoebozoan 
Mastigamoeba balamuthi while other 
amoebozoans Acanthamoeba and Dictyostelium 
lacked the gene. In addition to the two 
amoebozoan genera bearing PPi-PEPCK, 
PPi-PEPCK homologs were also present in some 
eukaryotes such as excavates, dinoflagellates, 
diatoms, and cryptophytes, which are distantly 
related to each other (39). In bacteria, limited 
number of species in Actinobacteria including P. 
freudenreichii used in this study, 
Verrucomicorobia, Bacteroidetes, Planctomycetes, 
Proteobacteria, Firmicutes and Spirochates 
possessed PPi-PEPCK homologs (Table 5): Many 
species were found to lack PPi-PEPCK even if 
many of them are closely related to 
PPi-PEPCK-bearing species. 
 
DISCUSSIONS 
In the present study, we successfully 
identified the gene encoding PPi-PEPCK, which is 
one of the key enzymes in the central metabolism 
and connects sugar and organic acids metabolisms, 
from E. histolytica and P. freudenreichii. We also 
found EhPEPCKs’ homologs were distributed in 
limited but diverse lineages of unicellular 
eukaryotes and bacteria, but not in archaea.  
In E. histolytica which lacks 
ATP/GTP-PEPCK and PEP carboxylase, 
PPi-PEPCK has been believed to work for the 
PPi- and oxaloacetate-producing direction (27,40). 
This is because supply of PPi is required to 
replenish PPi consumed by the PPi-utilizing 
enzymes in glycolysis, PPi-PFK and PPDK 
(4,12,41). However, it is uncertain whether PPi 
produced by PPi-PEPCK is truly essential because 
PPi is supplied as a byproduct of many reactions 
in vivo (3,42). Alternatively, it would be possible 
that PPi-PEPCK works for the PPi-utilizing 
direction when there is enough supply of PPi 
because of the following reason. E. histolytica is 
able to consume asparagine and aspartate from 
media (43), and these amino acids can be 
converted to oxaloacetate by aminotransferase 
(Fig. 5) (44). Although the oxaloacetate catabolic 
pathway has not been experimentally confirmed in 
this organism which lacks TCA cycle, the ameba 
may be capable of producing ATP from these 
amino acids by using the energy of PPi if 
oxaloacetate is further converted to PEP by 
PPi-PEPCK and then pyruvate by PPDK. Future 
experiments to investigate which direction is 
critical (or whether both directions are important) 
for viability in E. histolytica would give us deeper 
insight into the central metabolic pathway in this 
human parasite. 
E. histolytica has three isoforms of   
PPi-PEPCK which are strongly suggested to form 
hetero-trimers among the isoforms. This may be 
worth to mention because the two other species of 
Entamoeba have two isoforms and the four strains 
of the other eukaryotic human gut parasite 
Giardia intestinalis, for example, possess the 
single copy of this gene in the genomes (Fig. 6). 
Thus, it is still a key question whether each 
isoform of PPi-PEPCK from E. histolytica has 
different roles in the hetero-trimer and whether 
their roles are, if different, also shared amongst 
Entamoeba species. These issues should be 
examined in future to consider the roles of 
PPi-PEPCK in the human parasite E. histolytica. 
Most of the organisms possessing 
PPi-PEPCK homologs have canonical 
ATP/GTP-PEPCK genes and some of them have 
PEP carboxylases as well (Table 4), although E. 
histolytica possesses the three cytosolic 
PPi-PEPCKs but lacks the others. How these 
functional homologs are utilized/regulated in each 
organism is an open question: They might work 
for different directions to each other, or might 
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work in different environmental conditions. 
Especially, in some eukaryotes, these functional 
homologs might be utilized in different cellular 
compartments. For instance, a potential 
PPi-PEPCK from the unicellular alga 
Thalassiosira pseudonana (XP_002285950.1) is 
predicted to be cytosolic according to the in silico 
predictions (data not shown) as well as those of E. 
histolytica, while its ATP-PEPCK was confirmed 
to exist in mitochondria and two types of PEP 
carboxylases localize in mitochondria and the 
chloroplast, respectively (45). Although the 
localization of ATP-PEPCK and PEP carboxylases 
indicates PEP–oxaloacetate conversion occurs 
only in organelles of the diatom, our findings 
suggest that this reaction important for the central 
carbon metabolism can also occur in the cytosol 
of T. pseudonana. Our findings in this study 
would further open a new era for deeper 
understanding the central metabolism of various 
organisms. 
Identification of PPi-PEPCK also allows 
us to compare the amino acid sequences between 
PPi-PEPCK and the functional homologs, 
ATP-/GTP-PEPCK and PEP carboxylase. 
PPi-PEPCK bears none of the known catalytic 
domains such as oxaloacetate binding sites, kinase 
1a/P-loop, kinase-2 region, and nucleotide binding 
sites conserved in ATP- and GTP-PEPCK (22). In 
addition, no similarity in primary structure was 
observed between EhPEPCK and the functional 
homologs. Therefore, it is unlikely that 
PPi-PEPCK shares the common origin with ATP- 
and GTP-PEPCK/ PEP carboxylase. This is 
similar to the case between pyruvate kinase and 
PPDK/PEP synthase, but different from the cases 
of ATP-PFK/PPi-PFK and PPDK/PEP synthase 
that have most probably emerged from the single 
origins. Our findings further illuminate the 
complexity of evolution amongst the proteins, 
which are functionally redundant but utilize 
different phosphate donors (e.g., PPi and 
nucleotide triphosphates).   
Origins and evolutionary histories of 
PPi-PEPCKs were one of the most interesting 
points for authors. However, it was highly difficult 
to reconstruct a rooted tree of PPi-PEPCK because 
we could not find any proteins with sister 
relationships to PPi-PEPCK. In addition, whether 
the current distribution of PPi-PEPCK in the tree 
of life has shaped by lateral gene transfer or 
vertical inheritance followed by independent gene 
loss basically remains unclear because of the low 
resolution of the PPi-PEPCK tree (Fig. 6) with 
one exception for PPi-PEPCK in Dehalobacter 
sp.; the Dehalobacter homologue was nested in 
the clade of Actinobacteria although Dehalobacter 
belongs to Firmicutes, strongly suggesting 
actinobacterium-to-Dehalobacter lateral gene 
transfer.  
In summary, PPi-PEPCK was identified 
at molecular level for the first time since the 
activity was first demonstrated more than 50 years 
ago (24). It was also demonstrated that 
PPi-PEPCK was distributed in phylogenetically 
diverse but limited unicellular eukaryotes and 
bacteria, which would remodel the central 
metabolic pathways in various organisms. 
PPi-PEPCK has no clear evolutionary relationship 
with ATP- or GTP-PEPCK, in sharp contrast to 
the case of PPi- and ATP-PFK, and that of PPDK 
and PEP synthase, which have evolved from the 
single origins. These data suggest that, in order to 
substitute the energy and phosphate donors from 
PPi to nucleotide triphosphates, proteins have 
employed various strategies. 
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Figure legends 
 
Figure 1. SDS-PAGE analysis of purified native EhPEPCKs (A) and E. coli-expressed recombinant 
EhPEPCK1, EhPEPCK2, and PfPEPCK (B).  
A, Relative PPi-PEPCK activities in the selected MonoQ fractions (per volume) are shown on the top 
panel. Approximately 15 µl of the MonoQ fractions were applied to SDS-PAGE and stained with 
Coomassie Brilliant Blue (bottom). The arrow indicates the band corresponding to EhPEPCK. B, 
Homogeneity of purified E. coli-expressed recombinant EhPEPCK1 (labeled as PEPCK1), EhPEPCK2 
(PEPCK2), and PfPEPCK. One µg of recombinant proteins after the purification by MonoQ column was 
subjected to SDS-PAGE and Coomassie Brilliant Blue staining. 
 
 
Figure 2. Molecular weight of purified native EhPEPCKs. 
A, Chromatograph of native EhPEPCKs on Superdex200. The optical absorbance at 280 nm is shown 
with a thick line and the relative activity per volume of each fraction is shown with squares and a thin line. 
The highest activity per volume in all fractions was defined as 100%. B, Estimation of molecular weight 
of the proteins corresponding to the two peaks in “A” (a circle and a triangle). Standard proteins are 
shown with diamonds. 
 
Figure 3. WB analysis of EhPEPCKs with anti-HA (A) and anti-EhPEPCK (B and C) antibodies.  
A, Expression of EhPEPCK1-HA and 2-HA was confirmed. Note that proteins with the expected size 
(~130 kDa) were expressed. Amebic lysates containing 5 µg of protein were applied per lane on 
SDS-PAGE. B, Expression of EhPEPCKs in EhPEPCK1 or 2-HA expressing and mock control E. 
histolytica transformants. Total lysates of the above mentioned transformants (0.2-5 µg/ lane) and purified 
histidine-tagged PEPCK1 and 2 (2-50 ng/ lane) were electrophoresed on SDS-PAGE and subjected to WB 
analysis with anti-EhPEPCK antiserum. Note that lysates from mock transformant showed two bands 
while EhPEPCK1-HA expressing transformant showed one additional band (shown with an asterisk) 
corresponding to PEPCK1 with the HA-tag. Recombinant PEPCKs possesses the His-tag at the amino 
terminus and were purified using Ni-NTE and MonoQ columns to homogeneity. C, Specificity of 
anti-EhPEPCK antibody. Approximately 1 µg of lysate from the wild-type E. histolytica was reacted with 
anti-EhPEPCK antibody.  
 
Figure 4. Distribution of E. histolytica PEPCKs by fractionation and WB analysis.  
Trophozoites of mock, EhPEPCK1 or 2-HA-expressing transformants were mechanically disrupted, and 
centrifuged to separate into cytosolic and organelle fractions. Those fractions were reacted with 
anti-EhPEPCK, cysteine synthase 1 (CS1, cytosolic marker), or Cpn60 (a mitosomal matrix protein, used 
as an organellar marker) antibodies. Whereas approximately 5 µg of lysates was used for anti-PEPCK 
antibody, 20 µg of lysates were reacted with anti-CS1 and anti-Cpn60 antibodies. 
 
Figure 5. Glycolytic pathway and oxaloacetate—malate node of E. histolytica.  
Arrows indicate the reaction steps and their directions conducted by the enzymes in E. histolytica (46,47). 
PFK: phosphofructo kinase, PPDK: pyruvate phosphate dikinase, PEPCK: PEP carboxykinase. 
 
Figure 6. Phylogenic tree of PPi-PEPCKs and their homologs. Sequences were aligned by MAFFT and 
the dataset was subjected to the maximum likelihood analysis with RAxML ver. 7.2.8. Only bootstrap 
supports equal to or more than 85 are shown on each node. White letters in black boxes and black letters 
indicate eukaryotic and bacterial phyla, respectively. 
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Table 1 
Purification of PPi-PEPCK from E. histolytica 
 
 
Activity (U) 
Specific activity 
(U mg–1)  
Puridication (-fold) Yield (%) 
100k×g Sup. 75.4 0.165 1.0 100 
Butyl toyopeal 32.1 4.86 29.4 42.6 
MonoQ 8.06 34.0 206 10.7 
1U= Oxidation of 1 µ mol NADH min–1 
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Table 2 
Proteins detected by MS/MS analysis 
 
Identified Proteins  Accession Number 
Molecular 
Weight (kDa) 
Quantitative 
value 
hypothetical protein  (EhPEPCK1) EHI_166920 XP_654765 131 214 
hypothetical protein  (EhPEPCK2) EHI_030750 XP_650862 131 209 
hypothetical protein  (EhPEPCK3) EHI_198620 XP_655201 131 198 
hypothetical protein  EHI_192430 XP_656829 29 1 
hypothetical protein  EHI_189920 XP_652326 62 1 
Peptide Thresholds: Standard  
Protein Thresholds: 90.0% minimum and 1 peptide minimum 
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Table 3 
Relative quantification of EhPEPCKs isotypes 
  Peak area of monoisotopic ion 
Normalized relative ratio  
against common peptides 
Peptide 
EhPEPCK1
-HA IP 
EhPEPCK2
-HA IP 
Purification 
from cells 
EhPEPCK1 
-HA IP 
EhPEPCK2
-HA IP 
Purification 
from cells 
Unique to EhPEPCK1 
GTDYPILNIQELEALADLK 4.54E+07 3.96E+06 4.61E+06 
SDAIDVVAPLVDIIAEGDQESTAP
IDAR 4.09E+07 6.45E+06 2.17E+06 
NISDAIFEGK 2.41E+09 3.91E+08 6.71E+08 
Sum 2.50E+09 4.01E+08 6.78E+08 3.0E-01 5.5E-02 1.1E-01 
Specific to EhPEPCK2 and 3 
ITTAFANHFLR 9.22E+07 6.07E+08 1.68E+08 
KLESLANLK 3.81E+08 1.76E+09 8.54E+08 
LAGPLLEEVEESEVNHTTAPIDAR 2.62E+08 1.03E+09 2.54E+08 
Sum 7.35E+08 3.40E+09 1.28E+09 8.8E-02 4.6E-01 2.1E-01 
Unique to EhPEPCK2 
AVQEIFDHDFSKR 5.79E+06 2.38E+07 2.05E+07 6.9E-04 3.3E-03 3.3E-03 
Unique to EhPEPCK3 
GANLSSQYLR 2.14E+08 9.04E+06 3.37E+08 2.6E-02 1.2E-03 5.5E-02 
Common to all 
YLIEHGYLEPCPDVTYNGK 2.15E+08 1.87E+08 3.52E+08 
LFQRPDDAVFR 4.41E+09 4.39E+09 2.91E+09 
DFFPAAK 3.71E+09 2.74E+09 2.92E+09 
Sum 8.34E+09 7.32E+09 6.18E+09 1.0 1.0 1.0 
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Table 4 
Distribution of PPi-PEPCK and functional homologues in 10 represented genomes 
 
Organism Phylum 
Identity 
(%)* 
PEPCK 
ATP/GTP 
PEP 
carboxylase 
Eukaryote     
Entamoeba histolytica HM-1:IMSS Amoebozoa 100  - - 
Naegleria gruberi strain ATCC 30224 Heterolobosea  45  ATP - 
Guillardia theta CCMP2712 Cryptophyta  44  ATP + 
Thalassiosira pseudonana CCMP1335 Heterokontophyta 44  ATP + 
Giardia intestinalis strain ATCC 
50581 
Metamonada  39  GTP - 
Bacteria     
Pedosphaera parvula Ellin514 Verrucomicrobia 48  GTP - 
Planctomyces maris DSM 8797 Planctomycetes 46  ATP - 
Thioalkalivibrio nitratireducens  
DSM 14787 
Proteobacteria  46  GTP + 
Actinomyces graevenitzii C83 Actinobacteria 45  GTP** - 
Formosa agariphila KMM 3901  Bacteroidetes 42  ATP +** 
One organism from every phylum which has a PPi-PEPCK homolog with the highest identity to 
EhPEPCK in blastp search was listed. For bacteria, only phylum in which more than two organisms 
possess PPi-PEPCK homolog were shown. 
+, ATP, and GTP in the table indicates that the organism has a protein which shows 35% or higher identity 
to biochemically analyzed PEP carboxylase (from E. coli, UniProtKB; P00864), ATP-PEPCK (from E. 
coli, UniProtKB; P22259), and GTP-PEPCK (from Giardia intestinalis, XP_001709869.1), respectively. 
* Identity against EhPEPCK1 
** A protein with significant homology to the query while the identity is lower than 35% 
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Table 5  
Distribution of PPi-PEPCK in Bacteria 
Phylum 
No. of 
genomes*1 
No. of PPi-PEPCK containing 
genome*1 
Actinobacteria 910 104 
Aquificae 16 0 
Armatimonadetes 3 0 
Bacteroidetes/Chlorobi group 470 19 
Caldiserica 2 0 
Chlamydiae/Verrucomicrobia group 59 15 
Chloroflexi 25 0 
Chrysiogenetes 2 0 
Cyanobacteria  104 0 
Deferribacteres 6 0 
Deinococcus-Thermus 43 0 
Dictyoglomi 2 0 
Elusimicrobia 2 0 
Fibrobacteres/Acidobacteria group 46 1 
Firmicutes 1129 1 
Fusobacteria 25 0 
Gemmatimonadetes 5 0 
Nitrospinae 2 0 
Nitrospirae 10 0 
Planctomycetes 22 18 
Proteobacteria 2200 33 
Spirochaetes 80 2 
Synergistetes 18 0 
Tenericutes 140 0 
Thermodesulfobacteria 7 0 
Thermotogae 24 0 
Unclassified Bacterium 210 1 
*1: at 5th May 2015 in GenBank. 
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Fig. 1 
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Fig. 2 
 
  
Identification of PPi-type phosphoenolpyruvate carboxykinase 
 
22 
 
Fig. 3 
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Fig. 4 
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Fig. 5 
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Fig. 6 
